Skip to content
AnalystLens

Veeva Systems 8-K Report, Financial Results (Nov 20, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed November 20, 2025
Period End
November 20, 2025
Security
VEEV
In the record · 2016–202610-K1110-Q328-K94

VEEV filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 94 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Nov ’19Nov ’19
  2. Leadership change8-K · Aug ’22Aug ’22
  3. Leadership change8-K · Sep ’24Sep ’24

01—Abstract

Summary

Summary of the 8-K filed November 20, 2025. Cited figures are marked; the original filing is the authoritative source.

Veeva Systems Inc. (NYSE: VEEV) reported results for its fiscal 2026 third quarter ended October 31, 2025, in a press release furnished as Exhibit 99.1 to this Form 8-K.

Total revenues were $811.2 milliona, up 16% year over year from $699.2 million, and subscription services revenues were $682.5 million, up 17% from $580.9 million. GAAP operating income rose 33% to $240.9 million and GAAP net income rose 27% to $236.2 million, with GAAP fully diluted net income per share of $1.40 versus $1.13 a year earlier. Non-GAAP operating income was $364.9 million (up 20%) and non-GAAP fully diluted net income per share was $2.04 versus $1.75.

Management raised its full-year guidance. For the fiscal year ending January 31, 2026, Veeva now expects total revenues of $3,166 to $3,169 millionb, non-GAAP operating income of about $1,417 million, and non-GAAP fully diluted net income per share of approximately $7.93. For the fiscal fourth quarter, it guided to total revenues of $807 to $810 million, non-GAAP operating income of about $350 million, and non-GAAP fully diluted net income per share of approximately $1.92.

The company stated it cannot provide GAAP targets for these periods because certain excluded items, such as stock-based compensation, are difficult to predict. The filing highlights progress on Veeva AI, with the first CRM and commercial content agents on track for release in early December, and notes Vault CRM had 23 new customer additions, bringing it to 115 live customers.

Veeva Development Cloud, described as its largest go-forward opportunity, saw three top 20 biopharmas select its applications as enterprise standards in the quarter. The balance sheet showed cash and cash equivalents of $1.66 billionc and short-term investments of $4.98 billion at October 31, 2025, against deferred revenue of $822.5 million, and nine-month operating cash flow of $1.31 billion.

02—Key points

Key Highlights

  1. Q3 FY2026 total revenues of $811.2 million, up 16% year over year; subscription services revenues of $682.5 million, up 17%.
  2. GAAP operating income of $240.9 million (up 33%) and non-GAAP operating income of $364.9 million (up 20%); non-GAAP operating margin of 45.0% versus 43.5% a year earlier.
  3. GAAP fully diluted EPS of $1.40 (vs. $1.13) and non-GAAP fully diluted EPS of $2.04 (vs. $1.75).
  4. Full-year FY2026 guidance raised: total revenues of $3,166 to $3,169 million, non-GAAP operating income of about $1,417 million, and non-GAAP EPS of approximately $7.93.
  5. Q4 FY2026 guidance: total revenues of $807 to $810 million, non-GAAP operating income of about $350 million, and non-GAAP EPS of approximately $1.92.
  6. Veeva AI agents for CRM and commercial content are on track for release in early December, with R&D, quality, and additional commercial agents planned for 2026.
  7. Vault CRM added 23 customers in the quarter, reaching 115 live customers, and Veeva Development Cloud won three top 20 biopharma enterprise selections.

03—Questions

Frequently Asked Questions

  1. How did Veeva perform in its fiscal 2026 third quarter?

    Total revenues rose 16% year over year to $811.2 million, and subscription services revenues rose 17% to $682.5 million. GAAP net income increased 27% to $236.2 million, and non-GAAP net income increased 20% to $345.1 million.

  2. Did Veeva change its guidance?

    Yes. The filing says Veeva provided updated full-year guidance for the fiscal year ending January 31, 2026, with total revenues of $3,166 to $3,169 million, non-GAAP operating income of about $1,417 million, and non-GAAP fully diluted EPS of approximately $7.93. It also gave fourth-quarter guidance for revenues of $807 to $810 million and non-GAAP EPS of approximately $1.92.

  3. Why does Veeva not provide GAAP guidance for operating income and EPS?

    The company says it cannot reasonably predict certain items excluded from non-GAAP results, such as stock-based compensation charges, and that the effect of these excluded items may be significant.

  4. What are the key product developments?

    Veeva AI is progressing, with the first agents for CRM and commercial content on track for early December 2025 and R&D, quality, and additional commercial agents planned for 2026. Veeva Development Cloud, which the company calls its largest go-forward life sciences opportunity, had three top 20 biopharmas select its applications as enterprise standards in the quarter.

04—Continue

← View all 8-K filings